Remove digital fixing-clinical-trial-data-management
article thumbnail

2024 predictions: Experts comment on AI, ML and automation

Drug Discovery World

The PV model is broken, and in 2024, companies will need to assess how automation can fix operations. Without fixing the current, broken PV models, the continuous cycle of more complexity in the market, which then pushes organisations to incorporate automation into insufficient processes, will massively hinder PV operations.

Genome 139
article thumbnail

Revolutionizing Medicine and Public Health: The Emergence of Big Data in Healthcare

Roots Analysis

Big Data in healthcare refers to the vast amount of data that is continuously expanding and cannot be efficiently stored or processed using traditional tools. Within the healthcare sector, structured data includes demographic details, vital indicators (like, height, weight, blood pressure, blood glucose).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

DTx for women’s mental health – Woebot and postpartum depression

pharmaphorum

Digital therapeutics company Woebot Health has announced enrolment of the first patient in a pivotal clinical trial to evaluate the safety and efficacy of WB001, an investigational therapeutic for postpartum depression (PPD), granted Breakthrough Device designation by the US Food and Drug Administration (FDA) in 2021.

In-Vivo 105
article thumbnail

Investment fuels AI-driven development of breakthrough genomic medicines

pharmaphorum

“We founded Whitelab Genomics after realising the potential to use data, data science, and AI in a more systematic way to develop genomic therapies,” Del Bourgo says. The software applies machine learning to patient data to support therapeutics companies as they develop novel treatments.

Genome 105
article thumbnail

Roche to present a broad range of data across multiple cancer types at the ESMO Virtual Congress 2020

The Pharma Data

New and updated data from across our broad cancer portfolio including phase III results in breast, lung and prostate cancers. New integrated analyses from our tumour agnostic Rozlytrek ® (entrectinib) clinical development programme. Sign up here for the session on Saturday, 19 September, 16:00-16:30 CEST.

HR 52
article thumbnail

New collaboration between Novartis and Africa Medical Supplies Platform to facilitate supply of COVID-19 related medicines

The Pharma Data

“Following the successful listing of test kits, personal protective equipment, and clinical management devices, the African Union Chairperson has expanded our mandate to include groundbreaking medicines to treat COVID-19 patients in Africa,” said African Union Special Envoy, Strive Masiyiwa. For more information visit [link].

article thumbnail

Fuelling the efficiency of drug development through sensor data integration

pharmaphorum

But as we continue to digitise clinical trials, has access to new streams of valuable data become easier because “the data is IN the cloud”? Yet we remain unprepared to access reliable and trustworthy sensor data at scale. Data users must integrate in a tailored way to meet the specifications of each data partner.